RVL Pharmaceuticals plc
RVLPDelisted Nov 20, 2023- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001739426
RVL Pharmaceuticals plc was delisted on Nov 20, 2023; its insiders filed their last Form 4 on Oct 23, 2023; 32 institutions reported holding it in 13F filings for Q3 2023, worth $1.57M in total; no superinvestor held it.
Q2 2022 vs. Q1 2022
How the institutions holding RVL Pharmaceuticals plc changed between Q1 2022 and Q2 2022.
All holders in Q2 2022All holders in Q1 2022
| Measure | Q1 2022 | Of which not filed for Q2 2022 | Q2 2022 | Change |
|---|---|---|---|---|
| Holders | 36 | 1 | 38 | +3 |
| Shares | 16.4M | 19.0K | 16.4M | −60.9K (−0.4%) |
| Value | $27.8M | $32.0K | $22.2M | −$5.56M (−20.0%) |
1 institution that held it in Q1 2022 haven't filed for Q2 2022 yet. Not filing isn't selling, so the changes leave them out.
New holders (6)
Institutions that held RVL Pharmaceuticals plc at the end of Q2 2022 but not at the end of Q1 2022.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| AIGH Capital Management LLC | 84,993 | $116.0K | 0.05% |
| Millennium Management LLC | 48,125 | $65.0K | 0.00% |
| Prudential Financial Inc | 25,000 | $34.0K | 0.00% |
| SFMG, LLC | 10,000 | $14.0K | 0.00% |
| Simplex Trading, LLC | 1,598 | $2.00K | 0.00% |
| Allworth Financial LP | 75 | $0 | 0.00% |
Sold out (3)
Institutions that held RVL Pharmaceuticals plc at the end of Q1 2022 and filed for Q2 2022 without it.
| Institution | Shares, Q1 2022 | Value, Q1 2022 |
|---|---|---|
| Susquehanna International Group, LLP | 10,954 | $19.0K |
| Tower Research Capital LLC (TRC) | 3,022 | $5.00K |
| Northwestern Mutual Wealth Management Co | 275 | $0 |
Not filed for Q2 2022 yet (1)
Institutions that held RVL Pharmaceuticals plc at the end of Q1 2022 and haven't filed a 13F for Q2 2022. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q1 2022 | Value, Q1 2022 |
|---|---|---|
| Parametric Portfolio Associates LLC | 19,020 | $32.0K |